These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2932661)

  • 1. Evaluation of the 5-hydroxytryptamine receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in different rodent models of epilepsy.
    Löscher W; Czuczwar SJ
    Neurosci Lett; 1985 Sep; 60(2):201-6. PubMed ID: 2932661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serotonergic mechanisms in hippocampal kindled seizures--inhibitory effects of L-5-hydroxytryptophan and 8-hydroxy-2-(di-n-propylamino)tetralin].
    Nakamura M; Wada Y; Hasegawa H; Yamaguchi N
    No To Shinkei; 1992 Nov; 44(11):989-93. PubMed ID: 1296723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Engel JA; Hjorth S; Svensson K; Carlsson A; Liljequist S
    Eur J Pharmacol; 1984 Oct; 105(3-4):365-8. PubMed ID: 6239785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Yamada J; Sugimoto Y; Horisaka K
    Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
    Arvidsson LE; Johansson AM; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Magnusson T; Carlsson A; Andersson B; Wikström H
    J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure to antagonize the 8-hydroxy-2-di-n-propylamino)tetralin-induced facilitation of male rat sexual behavior by the administration of 5-HT receptor antagonists.
    Ahlenius S; Larsson K
    Eur J Pharmacol; 1984 Apr; 99(4):279-86. PubMed ID: 6234182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 8-Hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H] 5-HT recognition site.
    Middlemiss DN
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):18-22. PubMed ID: 6238235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT).
    Glennon RA
    Pharmacol Biochem Behav; 1986 Jul; 25(1):135-9. PubMed ID: 2944129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement by the putative 5-HT receptor agonist 8-OH-2-(di-n-propylamino)tetralin of the acoustic startle response in the rat.
    Svensson L; Ahlenius S
    Psychopharmacology (Berl); 1983; 79(2-3):104-7. PubMed ID: 6221350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.
    Hjorth S; Sharp T; Hacksell U
    Eur J Pharmacol; 1989 Nov; 170(3):269-74. PubMed ID: 2533557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin antagonizes the antinociceptive effect of morphine.
    Berge OG; Fasmer OB; Ogren SO; Hole K
    Neurosci Lett; 1985 Feb; 54(1):71-5. PubMed ID: 3156286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on central 5-hydroxytryptamine receptors.
    Björk L; Mellin C; Hacksell U; Andén NE
    Eur J Pharmacol; 1987 Nov; 143(1):55-63. PubMed ID: 2961582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of lordosis behavior by the putative 5-HT receptor agonist 8-OH-DPAT in the rat.
    Ahlenius S; Fernandez-Guasti A; Hjorth S; Larsson K
    Eur J Pharmacol; 1986 May; 124(3):361-3. PubMed ID: 2942412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Mellin C; Björk L; Karlén A; Johansson AM; Sundell S; Kenne L; Nelson DL; Andén NE; Hacksell U
    J Med Chem; 1988 Jun; 31(6):1130-40. PubMed ID: 2967376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased population spike amplitude in the dentate gyrus following systemic administration of 5-hydroxytryptophan or 8-hydroxy-2-(di-n-propylamino)tetralin.
    Klancnik JM; Baimbridge KG; Phillips AG
    Brain Res; 1989 Dec; 505(1):145-8. PubMed ID: 2532947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A C2-methylated derivative of the 5-hydroxy-tryptamine-receptor agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH DPAT).
    Mellin C; Liu Y; Hacksell U; Björk L; Andén NE
    Acta Pharm Suec; 1987; 24(4):153-60. PubMed ID: 2964167
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in monkeys.
    Mizuta E; Yamaguchi M; Kuno S
    Eur J Pharmacol; 1990 Mar; 178(1):125-7. PubMed ID: 2139614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.